Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Caution is needed when interpreting changes of matrix metalloproteinase-3 in patients with rheumatoid arthritis.

× No keyword cloud information.

5 in total

1. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.

Authors: C Ribbens; M Martin y Porras; N Franchimont; M-J Kaiser; J-M Jaspar; P Damas; F A Houssiau; M G Malaise
Journal: Ann Rheum Dis Date: 2002-02 Impact factor: 19.103

2. Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI.

Authors: Atsushi Kaneko; Daihei Kida; Kiwamu Saito; Masami Tsukamoto; Tomotaro Sato
Journal: Rheumatol Int Date: 2011-11-30 Impact factor: 2.631

3. Comment on: Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis.

Authors: Takao Nagashima; Seiji Minota
Journal: Rheumatology (Oxford) Date: 2011-03-15 Impact factor: 7.580

4. Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.

Authors: Mikiko Shinozaki; Eisuke Inoue; Ayako Nakajima; Masako Hara; Taisuke Tomatsu; Naoyuki Kamatani; Hisashi Yamanaka
Journal: Mod Rheumatol Date: 2007-10-19 Impact factor: 3.023

5. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis.

Authors: M Sharif; C Salisbury; D J Taylor; J R Kirwan
Journal: Arthritis Rheum Date: 1998-07

5 in total